Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen by unknown
Br/es Detinitive Report 
Circulating  Allergen-reactive  T  Cells from 
Patients with Atopic  Dermatitis  and Allergic 
Contact Dermatitis  Express the Skin-selective 
Homing  Receptor,  the Cutaneous 
Lymphocyte-associated  Antigen 
By Luis F. Santamaria Babi,* Louis J. Picker,r 
M. Teresa Perez Soler,* Khristina Drzimalla,~ Peter Flohr,~ 
Kurt Blaser,* and Conrad Hauser*  II 
From the *Swiss Institute of Allergy and Asthma Research, CH-7270 Davos, Switzerland; the 
*Laboratory of Experimental Pathology, Department of Pathology, University of Texas 
Southwestern Medical School, Dallas, Texas 75235; gKlinih fiir Dermatologie und Allergic, 
CH-7270 Davos, Switzerland; and the IIDepartment of Dermatology, H~pital Cantonal 
Universitaire, CH-1211 Geneva I4, Switzerland 
Summary 
The cutaneous lymphocyte-associated antigen (CLA) is the major T cell ligand for the vascular 
adhesion molecule E-selectin, and it has been proposed to be involved in the selective targeting 
of memory T cells reactive with skin-associated Ag to cutaneous inflammatory sites. To further 
investigate the relation of CLA and cutaneous T cell responses, we analyzed the CLA phenotype 
of circulating memory T  cells in patients with allergic contact dermatitis and atopic dermatitis 
(AD) alone vs in patients manifesting bronchopulmonary atop), (asthma with or without AD) 
and nonallergic individuals.  Significant T  cell proliferative responses to Ni,  a contact allergen, 
and to the house dust mite (HDM), an allergen to which sensitization is often observed in AD 
and/or asthma, was noted only in allergic and atopic individuals,  respectively. When the minor cir- 
culating CLA+CD3+CD45RO + subset was separated  from the major CLA-CD3+CD45RO § 
subpopulation in Ni-sensitive subjects, the Ni-dependent  memory T  cell response was largely 
confined to the CLA + subset. A  similar restriction  of the T  cell proliferative response to the 
CLA + memory subset was observed for HDM in patients with AD alone. In HDM-sensitive 
patients  with  asthma  with  or  without  AD,  however,  the  CLA-  subset  exhibited  a  strong 
antigen-dependent  proliferation,  in contrast  to patients  with  AD alone, whose CLA-  subset 
proliferated  very weakly  to  HDM.  In  asthma  with  or  without  AD,  the  HDM-dependent 
proliferation  slightly predominated  in  the CLA-  when compared to the CLA + subset.  The 
functional linkage between CLA expression and disease-associated T  cell effector function in 
AD  was  also demonstrated  by the  finding  that  the  circulating  CLA +  T  cell subset in  AD 
patients, but not nonatopic controls, selectively showed both evidence of prior activation (human 
histocompatibility antigen-DR expression) and spontaneous production of interleukin 4 but not 
interferon-qr. Taken together, these observations demonstrate the correlation of CLA expression 
on circulating  memory T  cells  and disease-associated memory T  cell responses in cutaneous 
hypersensitivity, and they suggest the existence of mechanisms capable of sorting particular T 
cell Ag specificities  and lymphokine patterns  into homing  receptor-defined memory subsets. 
l~ 
cent investigation  into  the physiology of lymphocyte 
homing has revealed considerable heterogeneity in the 
ability of memory T  ceils to home to and localize within 
various lymphoid and extralymphoid tissues (1-4). In effect, 
the overall  memory T  cell population is divided into mul- 
tiple subsets with varying, often tissue-specific,  homing capa- 
bilities. One of the best-characterized "extralymphoid" T cell 
homing specificities  is the skin (5-7), which has long been 
postulated to represent a functionally distinct immune com- 
partment and is a site of both localized T cell-mediated im- 
mune/inflammatory  disease and localized T  lineage malig- 
nancy (8,  9). 
The interaction between circulating T cells and microvas- 
cular endothelial cells is a critical determinant of the homing 
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T cell extravasation in the skin is mediated, at least in part, 
by  the  interaction  between  the  cutaneous  lymphocyte- 
associated antigen (CLA) on skin-homing T cells and its vas- 
cular counterreceptor, E-selectin, on inflamed superficial  dermal 
postcapillary venules (10-17).  In keeping with this hypoth- 
esis, CLA  is  expressed  by a  minor subset  of CD45RO § 
memory T  cells in peripheral blood, by essentially all such 
cells in cutaneous sites of chronic inflammation, but by rela- 
tively few T  cells in extracutaneous inflammatory sites (10, 
14). Moreover, CLA is expressed  by the malignant T  cells 
of chronic-phase cutaneous T cell lymphoma (mycosis fun- 
goides and Srzary syndrome), but not by non-skin-associated 
T cell lymphomas/leukemias (10, 15). CLA expression is regu- 
lated at the time of T cell activation by microenvironmental 
factors (including cytokines such as TGF-fll and IL-12) and 
has been demonstrated to be selectively induced on T  cells 
undergoing the virgin to memory transition in skin-draining 
peripheral lymph nodes (PLN) (16 and Picker, L. J., unpub- 
lished data). 
Since CLA is selectively associated with infiltrating T cells 
of the skin, it is possible  that a similar association of CLA 
and skin-associated  T cell functions exists in the blood. To 
investigate this possibility, we compared the distribution of 
disease-associated  memory T  cells  in  two  skin-associated 
and MHC-restricted  (18-20)  immune  responses  to  well- 
characterized Ag's-allergic contact dermatitis (CD) to Ni 
and atopic dermatitis (AD) associated with hypersensitivity 
to the house dust mite (HDM)--to that of T  cells specific 
for tetanus toxoid (TT) in normal individuals, and to disease- 
associated T  cells in patients who manifest bronchopulmo- 
nary atop),  (asthma). Our results demonstrate the associa- 
tion of CLA expression  on circulating memory T  cells and 
cutaneous immune function in AD and CD, and they pro- 
vide a model for the study of the mechanisms responsible 
for the selective distribution of the memory T cell repertoire 
among the different homing marker-defined T cell subsets. 
Materials and Methods 
Study Population.  14 patients with AD alone (mean age: 36 yr), 
4 patients with AD plus asthma (mean age: 36 yr), 3 patients with 
asthma alone (mean age: 36 yr), 9 patients with Ni contact allergy 
(mean age: 35 yr), and 7 healthy controls (mean age: 36 yr) were 
analyzed in this study. All patients with AD fulfilled the criteria 
of Hanifin and Rajka (21). Atopics were skin prick test positive 
for HDM and presented HDM-specific IgE in serum. Ni-allergic 
CD patients showed positive epicutaneous patch test reactions to 
0.5% NiSO4 in Vaseline read at 48 and 72 h. Healthy controls had 
no history of atop),. 
Antibodies and Ag's.  mAb HECA-452 against CL available  from 
L. J. Picker has previously been described (10). The mAbs anti- 
CD45RO .(PE conjugated), anti-HLA-DR (PE conjugated), and 
anti-CD45RA  were purchased from  Immunotech  (Marseille, 
France). The anti-CD16 mAb was obtained from the Central Lab- 
oratory of Blood Transfusion of the Red Cross (Amsterdam, The 
Netherlands) and anti-CD3-ECD from Coulter Corp. (Hialeah, 
FL). FITC-conjugated streptavidin was obtained from Tago, Inc. 
(Burlingame, CA).  Goat anti-rat  (H+L) biotin-SP-conjugated 
F(ab')2 and goat anti-rat (H+L) biotin-SP--conjugated  F(ab')z cou- 
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pied to FITC were purchased from Immunotech. Anti-CD14, anti- 
CD19, and streptavidin-conjugated  magnetic microbeads  were ob- 
tained from Miltenyi Biotech (Bergisch Gladbach, Germany). 
HDM (Dermatophagoides  pteronyssinus) extract was obtained  from 
Haarlems Allergenen Laboratorium (Haarlem, The Netherlands). 
Purified Dermatophagoides pteronyssinus allergen (DerPl) was from 
Dr. H. Lrwenstein (ALK, Horshotm, Denmark). Purified TT was 
obtained from the Swiss Serum and Vaccination Institute (Bern, 
Switzerland). 
Preparation  of  CLA-enriched and  CLA-depleted Memory  T 
Cells.  PBMC were isolated by Ficoll density gradient (Biochrom 
K.G., Berlin, Germany)  centrifugation and resuspended  in DMEM 
(Gibco, Basel, Switzerland) supplemented with 10 mM Hepes 
(Gibco), 5 mM EDTA (Fluka Chemie AG, Buchs, Switzerland), 
2%  FCS (Sera-Lab, Crawley Down,  UK),  100 U/ml penicillin 
(Gibco), and 100 #g/ml streptomycin (Gibco). Cells were mixed 
with anti-CD14 and anti-CD19 conjugated to magnetic microbeads 
(Miltenyi  Biotech) and were passed through the magnetic activated 
cell separation system (MACS; Miltenyi Biotech) to obtain auto- 
logous APC. The CD14- and C19-depleted ceils were incubated 
with anti-CD45RA and anti-CD16 for 30 rain on ice. Washed  cells 
were mixed together with goat anti-mouse-conjugated magnetic 
microbeads to negatively  select a population of CD45RO + T cells. 
CD45RO + T  cells were incubated with anti-CLA HECA-452 
mAb for 30 rain on ice. Washed cells were then incubated with 
biotin-conjugated goat anti-rat (H + L) for 30 min on ice. Finally, 
washed cells were mixed with streptavidin  conjugated to magnetic 
microbeads and were passed through the MACS. Both nonmag- 
netic (CLA-) and magnetic (CLA +) calls were recovered by se- 
quential elution. 
Proliferation Assays.  The  CLA-enriched and  CLA-depleted 
memory T  cells (5  ￿  104 cells per well) were incubated with 
700 R irradiated autologous APC (104 cells per well) and with or 
without HDM (30 #g/ml), DerP1 (10 #g/ml), or NiSO4 (20 
#g/ml) in 250 #1 of RPMI 1640 containing 10% complement- 
inactivated  autologous  serum, 2 mM t-glutamine (Gibco), 100 U/ml 
penicillin, and 100 #g/ml streptomycin  in 96-well U-bottom plates 
(Falcon Labware, Becton Dickinson and Co., Cockeysville,  MD). 
The cultures were pulsed with 1 #Ci of [3H]thymidine  (DuPont/ 
New England Nuclear, Boston, MA) after 5 d, and the incorpora- 
tion of the labeled nucleotide was determined after 16 h. 
Cell Staining and Flow Cytomet~  Five-parameter  analysis  was 
performed  on an Epics Profile  (Coulter Corp.) installed  with a power 
pack and equipped with a 488-nm argon laser. Fluorescence 1 was 
measured using a 525-nm band pass filter; fluorescence  2 was mea- 
sured with a band pass filter of 575 nm, and fluorescence 3 was 
measured with a band pass filter of 635 nm. Typically, 105 cells 
were sequentially stained with HECA-452, goat anti-rat (H+L) 
conjugated to FITC, CD3-ECD, and CD45RO-PE, or HLA-DR- 
PE. Stained cells were fixed in 2% paraformaldehyde  in PBS and 
stored at 4~  until they were analyzed.  As a negative control, cells 
stained with FITC-conjugated goat anti-rat IgM were used. Cells 
were analyzed using the Gate Way software (Coulter Corp.). 
11_,4 and IFN-  7 Assays.  mAbs  to IFN--y and Ib4 were kindly 
provided by Dr. S. Alkan and Dr. C. Heusser, respectively  (both 
from Ciba-Geigy,  Basel, Switzerland), and ELISA assays  were per- 
formed as described (22). 
StatisticaIAnalysis.  Data were analyzed  with the Mann-Whitney 
U test. The deviations  shown in the results section  represent 1 SEM. 
T Cell Response Confined 
Results 
As delayed hypersensitivity to Ni manifesting as CD is ex- 
clusively expressed in the skin, we investigated the in vitro 
to Circulating  Allergen-Reactive  Cells proliferative response of CLA + and CLA-  T  cells to this 
allergen that is recognized in the context of MHC class II 
molecules (19, 23). Significant T cell proliferation to Ni was 
only observed in individuals with a positive patch test to Ni 
(data not shown). In these sensitive individuals (mean: 10.1% 
CLA + in CD3 + PBMC; range:  7.0-18.3%),  the prolifera- 
tive response to the allergen was exclusively confined to the 
CLA + circulating  memory T  cell subset in  seven  of nine 
subjects and nearly exclusively confined to this subset in the 
other two subjects (Fig. 1 A; p  =  0.0025 for the comparison 
of CLA + and  -  subsets for the overall group of nine sub- 
jects). In contrast, the proliferative response to TT was not 
confined to CLA + memory T  cells in five healthy subjects 
(mean:  12.0% CLA + in CD3 + PBMC; range: 7.1-20.3%) 
and in four Ni-sensitive individuals (Fig.  1 B), demonstrating 
that not all antigen-induced memory T cell responses consis- 
tently predominate  in the CLA + subset. 
AD is another skin-based T cell-mediated chronic hyper- 
sensitivity disorder in which responsible allergens can some- 
times be identified. Unlike CD to Ni, however, atopic indi- 
viduals may manifest hypersensitivity responses to a particular 
allergen in skin alone (AD), in an extracutaneous tissue alone 
(primarily the lung, as in asthma), or in multiple tissues (ei- 
ther  simultaneously in  skin and lung  or often at different 
times). The physiologic factors responsible for determining 
these tissue "preferences" of disease expression are unknown, 
but they may reflect differences in the regulation of homing 
receptor expression on developing memory T  cells.  To test 
this hypothesis, we identified a group of atopic individuals 
with demonstrable hypersensitivity and MHC-restricted (18, 
20, 24-26) T cell reactivity to HDM who manifested atopic 
symptoms in the skin alone (n  =  7) or in the lung  alone 
or with the skin (n  =  7). As shown in Fig. 2 A, memory 
T cell proliferative responses to HDM and DerP1 were pref- 
erentially detected in CLA + T  cells in six out of seven pa- 
tients with AD alone (p  =  0.006;  mean:  7.3%  CLA + in 
CD3 + PBMC; range:  2.5-11.6%).  In contrast, in those in- 
dividuals manifesting asthma alone (mean:  8.2% CLA + in 
CD3 +  PBMC;  range:  3.4-13.0%)  or  asthma  with  AD 
(mean:  14.3% CLA + in CD3 + PBMC; range:  2.9-22.4%), 
the  CLA-  subset  exhibited  a  stronger  HDM-dependent 
proliferative  response than the CLA-  subset in patients with 
AD alone (p =  0.0045; Fig. 2). In all the patients with asthma 
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Figure  1,  The Ni-induced proliferative response of circulating T  cells 
from subjects with Ni sensitivity is largeIy confined to the CLA + subset. 
CLA + (solid bars) and CLA-  CD45RO + (open bars) T  ceils  from indi- 
viduals with contact sensitivity to Ni (A) or sensitivity to TT (B) were 
incubated with or without Ni (A) or TT (B) in the presence of autolo- 
gous CD14+CD19 + ceils. Individuals tested with TT were either healthy 
controls or individuals with Ni sensitivity (S.U., S.C., H.H.).  cpm >0 rep- 
resent cpm in the presence of Ag minus cpm from cultures without Ag; 
cpm <0 represent cpm from cultures without Ag. 
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Figure  2.  The HDM- and DerPl-induced proliferative response of cir- 
culating T cells from patients with AD is largely confined to the CLA + 
subset. CLA * (solid bars) and CLA- CD45KO * (open bars) T  cells from 
patients with AD alone (A) and patients with asthma with (S.I.,  TC., 
M.A., E.R.)  or without AD (T.S., W.R., E.W.) (B) were incubated with 
or  without  HDM  (DPT)  or  DerP1  in  the  presence  of  autologous 
CD14+CD19 + cells. The proliferative response was determined after 5 d. 
cpm >0 represent cpm in the presence of Ag minus cpm from cultures 
without Ag; cpm <0 repro-sent cpm from cultures without Ag. 
Santamaria Babi et al.  Brief Definitive Report with or without AD, there was a slightly higher prolifera- 
tive response  to HDM in the CLA-  subset. 
To further investigate the linkage between disease-associated 
T  cells in AD and CLA expression,  we asked whether pa- 
tients with active AD may have increased  numbers of cir- 
culating activated T cells, and if so, whether these cells ex- 
pressed  CLA.  As  shown in Fig.  3 A, patients with active 
AD did indeed demonstrate a significantly higher number 
of cells expressing the activation marker HLA-DR within 
the  circulating CLA +  T  cell  subset  as  compared  to  the 
CLA- subset (mean: 6.18  _+  1.6%,  .1 SEM, vs. 1.56  _+  0.6, 
p  =  0.0035).  This is in contrast to the situation in normal 
individuals, who demonstrate much lower overall HLA-DR 
expression and no preferential expression of the CLA + T cell 
subset (Fig. 3 B). Moreover,  in AD subjects (Fig. 3 C), un- 
like in normal control subjects (data not shown), a high level 
of spontaneous IL-4 production was observed  after in vitro 
incubation of the CLA §  but not CLA-, memory T  cell 
subset.  Furthermore, IFN-3' was not detected in these sub- 
jects in either T  cell subset (data  not shown). Given that 
IL-4-producing (Th2-type) T  cells have been strongly im- 
plicated in the pathogenesis of AD (27-31),  these results sug- 
gest that when dermatitis is the primary presentation of atopy, 
disease-associated effector T cells are primarily in the CLA + 
memory subset. 
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Figure  3.  CLA  + circulating  T cells from patients with AD contain 
an increased percentage of HLA-DR  + cells  and spontaneously  release in- 
creased amounts  of IL-4. PBMCs  from  patients with AD (A) and healthy 
controls (B) were stained  with mAb to CD3, HLA-DR,  and CLA. CD3 + 
cells were gated and the percentage  of HLA-DR  + cells within the CLA  + 
(solid bars) and CLA - (open bars) subsets was determined.  Memory  T cells 
were isolated from PBMCs of patients with AD and cultured with 
CD14 §  and CD19*  cells. IL-4 was determined in  the 48-h super- 
natant (C). 
Discussion 
AD and allergic CD are two independent forms of cuta- 
neous allergy that are associated with an allergen-dependent 
T  cell response  (32).  In animal models, it has clearly been 
documented that allergic  CD is T  cell dependent and that 
the allergen-specific T cells migrate into the site of allergen 
application (33). There they may induce the clinical features 
of dermatitis, which include swelling, erythema, and secondary 
infiltration, first by granulocytes and later by mononuclear 
cells. There is evidence that allergic CD is a type 1 Th re- 
sponse (34). Although it has not formally been shown that 
type 2 Th are responsible  for AD,  type 2 Th clones  with 
specificity for atopy-related Ag's can be derived from the skin 
of patients with AD (27-29).  In addition, so-called late-phase 
cutaneous reactions in atopics contain many T cells and ex- 
hibit positive signals for type 2 Th lymphokines by in situ 
hybridization (30).  Although there is presently no animal 
model for AD, activated type 2 Th injected into the skin can 
induce inflammation that is dependent on IL-4 (31). Simi- 
larly, type 2 Th cytokines are found in bronchoalveolar cells 
from patients with allergic asthma (35, 36). Such IL-4- and 
IL-5-producing T cells in the bronchial wall may be respon- 
sible for the recruitment ofeosinophils and other proinflam- 
matory cells, as well as for the late inflammatory phases of 
asthma. 
In addition to the skin-selective  expression of CLA in organ- 
infiltrating T  cells,  evidence  linking  CLA  expression  of 
memory T cells to skin-selective homing includes (a) the pat- 
tern of expression of other tissue-selective homing receptors 
on  the  CLA +  T  subset  (high L-selectin;  low o~437- and 
ae37-integrins;  14); (b)  the  high  expression  of CLA on 
allergen-specific T cell clones from an AD patient vs the lack 
of CLA on non-Ag-specific blood-derived clones from the 
same patient (13); and (c) the selective up-regulation of CLA 
on T  cells undergoing the virgin to memory transition in 
skin-draining PLNs vs mucosal secondary lymphoid tissues 
(16). Here we provide further evidence for the association 
of CLA and skin immune responses by demonstrating that 
the circulating Ag-specific memory T cells in subjects with 
skin-restricted chronic inflammation conditions are highly 
restricted to the CLA + subset.  Moreover,  in AD patients, 
circulating HLA-DR-expressing and "spontaneously" IL- 
4-producing T cells were selectively enriched in the CLA § 
1938  T Cell Response Confined to Circulating Allergen-Reactive  Cells subset.  In contrast, the CLA- subset was the major source 
of HDM reactivity in HDM-sensitive asthmatic individuals. 
Taken together, our observations are compatible with the skin- 
homing function of CLA, and they suggest the existence of 
mechanisms that are capable of selectively targeting memory 
T ceils with a particular Ag reactivity and lymphokine pat- 
tern into a distinct homing marker-defined subset. 
We have previously proposed that homing receptor expres- 
sion, like effector functions such as cytokine synthesis poten- 
tial (37), is regulated at the time ofT cell activation, initially 
during the virgin to memory transition in secondary lym- 
phoid tissue, and perhaps also at subsequent "reactivations" 
in secondary lymphoid tissues or extralymphoid effector sites 
(16). However, similar to what has been described for cytokine 
production, the specific regulatory elements directing homing 
function in vivo are likely to be complex and thus may not 
always correlate with anatomic site of antigen deposition alone. 
Nevertheless,  this hypothesis would predict that T ceils reac- 
tive with an Ag that consistently is encountered by the im- 
mune system in CLA-inducing microenvironment would, over 
time, preferentially accumulate in the skin-homing CLAhig  h, 
L-selectin  +,  ot4flT-integrin-  memory T  cell subset. 
Contact allergens such as Ni would clearly fit into the cat- 
egory of tissue (e.g.,  skin)-associated  Ag's, and our finding 
that Ni-reactive memory T cells are almost exclusively in the 
CLA + subset supports this hypothesis. It is much less clear 
how Ag's such as HDM interact with the immune system, 
and indeed the varied organs of atopy manifestations in different 
patients and in the same patient at different times suggest 
variability of the microenvironment in which specific T cells 
of atopics encounter HDM Ag. Clearly, however, in some 
individuals with atopic manifestations restricted to the skin, 
HDM-specific T cells are preferentially in the CLA + mem- 
ory subset.  It remains to be determined in these patients 
whether this preferential CLA induction on HDM-reactive 
memory T  cells results from HDM preferentially entering 
the body via cutaneous routes or from genetic or other regula- 
tory  influences  promoting  CLA  induction in  non-skin- 
associated  microenvironments. 
This work was supported by the Swiss National Foundation for Scientific  Research grants 31-29967.90 
and 31-39430.93, and by the EMDO Stiftung. Dr. L. F. Santamaria Babi's contribution was supported 
by the Walter Siegenthaler Stipendium. Dr. Picker's contribution was supported by National Institutes 
of Health grant AI-31545. 
Address correspondence to Dr. Luis  F. Santamaria Babi, Swiss Institute for Allergy and Asthma Research, 
Obere Strasse 22, 7270 Davos, Switzerland. 
Received for Fublication 16 November 1994 and in revised form 22 December  1994. 
References 
1.  Picker,  L.J., and E.C. Butcher. 1992. Physiological  and molec- 
ular mechanisms of  lymphocyte homing. Annu. Rev. Immunol. 
10:561-591. 
2.  Springer, T.A. 1994. Traffic  signals for lymphocyte recircula- 
tion and leukocyte emigration: the multistep paradigm. Cell. 
76:301-314. 
3.  Picker,  L.J. 1994. Control of lymphocyte homing. Curt. Opin. 
Immunol. 6:394-406. 
4.  Mackay, C.R. 1993. Homing of naive, memory and effector 
lymphocytes. Curr. Opin. Immunol. 5:423-427. 
5.  Mackay,  C.R., W. Marston, and L. Dudler. 1992. Altered pat- 
terns of T cell migration through lymph nodes and skin fol- 
lowing antigen challenge. Eur. J. Immunol. 22:2205-2210. 
6.  Rose, M.L., D.M. Parrott, and R.G. Bruce. 1976. Migration 
of lymphoblasts to the small intestine. II. Divergent migra- 
tion of mesenteric and peripheral immunoblasts to sites of 
inflammation in the mouse. Cell. Immunol. 27:36-46. 
7.  Issekutz, T.B., W. Chin, andJ.B. Hay. 1980. Lymphocyte  traffic 
through granulomas: differences in the recovery of indium- 
111-labeled lymphocytes in afferent and efferent lymph. Cell. 
Immunol. 54:79-86. 
8.  Bos, J.D., I. Zonneveld, P.K. Das, S.R. Krieg, C.M. van der 
Loos, and M.L. Kapsenberg. 1987. The skin immune system 
(SIS): distribution and immunophenotype of lymphocyte sub- 
populations in normal human skin. J.  Invest. Dermatol. 88: 
569-573. 
9.  Edelson,  R.L. 1980. Cutaneous T cell  lymphoma: mycosis  fun- 
goides, S6zary syndrome, and other variants. Am. Acad. Der- 
matol. 2:89-106. 
10.  Picker, L.J., S.A. Michie, L.S. Rott, and E.C. Butcher. 1990. 
A unique phenotype of skin-associated  lymphocytes  in humans: 
preferential expression of the HECA-452 epitope by benign 
and  malignant  T-cells at  cutaneous  sites. Am.  J.  Pathol. 
136:1053-1068. 
11.  Picker,  L.J., T.K. Kishimoto, C.W. Smith, R.A. Wamock, and 
E.C. Butcher. 1991. ELAM-1 is an adhesion molecule for skin- 
homing T cells. Nature (Lond.). 349:796-799. 
12.  Berg, E.L., T. Yoshino, L.S. Rott, M.K. Robinson, R.A. War- 
nock, T.K. Kishimoto, L.J. Picker, and E.C. Butcher. 1991. 
The cutaneous  lymphocyte  antigen is a skin lymphocyte  homing 
receptor for the vascular  lectin endothelial cell-leukocyte  adhe- 
sion molecule 1. J. Exlx Med. 174:1461-1466. 
13.  Rossiter,  H., G.C. Mudde, F. van Reijsen, F. Kalthoff,  C.A.F.M. 
Bruijnzeel-Koomen,  L.J. Picker, and T.S. Kupper. 1994. Disease- 
related T cells from atopic skin express cutaneous lymphocyte 
antigen and sialyl Lewis X determinants, and bind to both 
E-selectin and P-selectin. Eur. j. Immunol. 24:205-210. 
14.  Picker, L.J., R.J.  Martin,  A. Trumble, L.S. Newman, P.A. 
Collins, P.R. Bergstresser, and D.Y.M. Leung. 1994. Differen- 
tial expression of lymphocyte homing receptors by human 
1939  Santamaria  Babi et al.  Brief  Definitive Report memory/effector T cells in pulmonary vs. cutaneous immune 
effector sites. Eur. J. Immunol.  24:1269-1277. 
15.  Heald, P.W., S.-L. Yah, R.L. Edelson, R. Tigelaar, and L.J. 
Picker. 1993. Skin-selective  lymphocyte homing mechanisms 
in the pathogenesis of leukemic cutaneous T-cell lymphoma. 
J. Invest. Dermatol. 101:222-226. 
16.  Picker,  L.J., J.R. Treer, B. Ferguson-Darnell,  P.A. Collins, P.R. 
Bergstresser, and L.W.M.M. Terstappen. 1993. Control of  lym- 
phocyte recirculation in man. II. Differential regulation of the 
cutaneous lymphocyte-associated antigen,  a  tissue-selective 
homing  receptor  for  skin-homing  T  cells. J.  Immunol. 
150:1122-1136. 
17.  Santamaria, L.F., R. Moser, M.T. Perez Soler, L.J. Picker, K. 
Blaser, and C. Hauser. 1995. The migration of skin-homing 
T calls across cytokine-activated  human endothelial cell layers 
involves interaction of the cutaneOUS  lymphocyte-associated  an- 
tigen (CLA), the very late antigen-4 (VLA-4) and the lym- 
phocyte function-associated  antigen-1 (LFA-1).J.  Immunol. 154: 
1543-1550. 
18.  Yssel,  H., K.E. Johnson, P.V. Schneider,  J. Wideman, A. Terr, 
R. Kastelein,  andJ.E. De Vries. 1992. T cell activation-inducing 
epitopes of the house dust mite allergen Der pI. Proliferation 
and lymphokine production patterns by Der pI-specific CD4 + 
T cell clones. J. Imraunol. 148:738-745. 
19.  Kapsenberg, M.L., T. Van der Pouw-Kraan, F.E. Stiekema, A. 
Schootemeijer, andJ.D. Bos. 1988. Direct and indirect nickel- 
specific stimulation of T lymphocytes from patients with al- 
lergic contact dermatitis to nickel.  Eur.J. Immunol. 18:977-982. 
20.  Lin, K.L., K.H. Hsieh, J.K. Huang, and S.Y. Wang. 1992. 
Major histocompatibility complex (MHC) class II restriction, 
lymphokine production, and IgE regulation of house dust mite- 
specific T cell clones. J.  Clin. Immunol.  12:271-280. 
21.  Hanifin,  J.M., and G. Rajka. 1980. Diagnostic  features  ofatopic 
dermatitis. Acta Derm.  Venereol. (Stockh.). 92:44-47. 
22.  Brinkman, V., T. Geiger, S. Alkan, and C.H. Heusser. 1993. 
Interferon o~ increases the frequency  of  Interferon y-producing 
human CD4 + T cells, f  Exp.  Med. 178:1655-1663. 
23.  Sinigaglia, P., D.  Scheidegger, G.  Garotta,  P.  Scheper, M. 
Pletscher, and A. Lanzavecchia.  1985. Isolation and character- 
ization of Ni-speciflc  T cell  clones  from patients  with Ni-contact 
dermatitis, f  Immunol.  135:3929-3932. 
24.  O'Hehir, R.E.O., andJ.R. Lamb. 1991. The cellular and mo- 
lecular basis of the human T cell response to Dermatophagoides 
SHX (house dust mite). Parasite Immunol.  (Oxf.).  13:109-119. 
25.  Lamb,  J.R., and R.E. O'Hehir.  1989. HLA class II restriction 
specificity  ofDermatophagoides spt~ reactive  T lymphocyte  clones 
that support IgE synthesis. Clin. Exp. Allergy. 19:389-393. 
26.  O'Hehir, R.E., R Mach, C. Berte, R. Greenlaw,  J.-M. Tiercy, 
V. Bal, K.I. Lechler,  J. Trowsdale, and J.R. Lamb. 1990. Di- 
rect evidence  for a functional role of HLA-DRB1 and -DRB3 
gene products in the recognition  ofDermatophagoides sHa (house 
dust mite) by helper T lymphocytes.  Int. Iramunol. 2:885-892. 
27.  Van der Heijden, EL.,  E.A. Wierenga, J.D. Bos, and M.L. 
Kapsenberg. 1991. High frequency of IL-4-producing CD4 + 
allergen-specific T lymphocytes in atopic dermatitis lesional 
skin. J. Invest. Dermatol. 97:389-394. 
28.  Sager,  N., A. Feldmann, G. Schilling,  P. Kreitsch, and C. Neu- 
mann. 1992. House dust-mite specific T cells in the skin of 
subjects with atopic dermatitis: frequency and lymphokine 
profile in the allergen patch test. J.  Allergy  Clin. Immunol. 
89:801-810. 
29.  Van Reijsen, F.C., C.A.F.M. Bruijnzeel-Koomen,  ES. Kalthoff, 
E. Maggi, S. Romagnani, J.K.T. Westland, and G.C. Mudde. 
1992. Skin-derived aero-allergen specific  T cell clones of Th2 
phenotype in patients with atopic dermatitis. J. Allergy. Clin. 
Immunol.  90:184-193. 
30.  Kay, A.B., S. Ying, V. Varney, M. Gaga, S.R. Durham,  R. 
Moqbel, A.J. Wardlaw,  and Q. Hamid. 1991. Messenger  RNA 
expression of the cytokine gene cluster interleukin 3 (IL-3), 
IL-4, Ib5,  and granulocyte/macrophage colony-stimulating 
factor, in allergen-induced late-phase cutaneous reactions in 
atopic subjects.  J. Exl~ Med. 173:775-778. 
31.  Mfiller, K.M., F. Jaunin,  I. Masouy~,  J.-H. Saurat, and C. 
Hauser. 1993. Th2 cells mediate IL-4-dependent local tissue 
inflammation, j. Immunol.  150:5576-5584. 
32.  K~gi,  M.K., B. Wfithrich, E. Montano,  J. Barandun,  K. Blaser, 
and C. Walker. 1994. Differential cytokine profiles in periph- 
eral blood lymphocyte supernatants and skin biopsies from pa- 
tients with different forms of atopic dermatitis, psoriasis and 
normal individuals. Int, Arch. Allergy Immunol. 103:332-340. 
33.  Ferguson, T.A., and T.S. Kupper. 1993. Antigen-independent 
processes in antigen-specific  immunity. A role for cr4 integrin. 
J. Immunol.  150:1172-1182. 
34.  Kapsenberg,  M.L., E.A. Wierenga, F.E.M. Stiekerna, A.M.RC. 
Tiggelman, andJ.D. Bos. 1992. Thl lymphokine production 
profiles of Ni-specific CD4 + T-lymphocyte clones from Ni 
contact allergic  and non-allergic  individuals.J. Invest. Dermatol. 
98:59-63. 
35.  Walker, C.,  E. Bode, L. Boer, T.T. Hansel, K. Blaser, and 
J.-C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics 
have distinct patterns of T-cell activation and cytokine produc- 
tion in peripheral blood and bronchoalveolar  lavage. Am. Rev. 
Respir. Dis. 146:109-115. 
36.  Walker,  C., J.-C. Virchow,  Jr., P.L.B. Bruijnzeel,  and K. Blaser. 
1991. T cell subsets and their soluble products regulate eo- 
sinophilia in  allergic and  nonallergic asthma, j.  Immunol. 
146:1829-1835. 
37.  Paul, W.E., and R.A. Seder. 1994. Lymphocyte  responses and 
cytokines. Cell. 76:241-251. 
1940  T Cell Response Confined to Circulating Allergen-Reactive  Cells 